Remove Article Remove Communication Remove Process Improvement
article thumbnail

Enhancing Patient Satisfaction in Healthcare: Importance & Key Strategies

Viseven

A friendly, empathetic attitude and attentive communication go a long way in making patients feel valued and cared for. Clear communication Patients want to feel heard and informed. Communication: Were your condition and treatment options explained clearly? Lets break down the essentials that make or break a patients experience.

article thumbnail

Pharma News: Latest Trends and Insights for Marketing Teams

Pharma Marketing Network

In this article, well explore the key trends, technologies, and challenges shaping the pharma marketing world today. Automation: Email marketing and CRM tools streamline communication, saving time while maintaining personalization. Because as marketers, youre not just selling productsyoure delivering solutions that change lives.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oligonucleotides: A Cornerstone for Therapeutics & More

ISPE

In this article, we’ll explore some innovations and improvement opportunities in the science, manufacturing processes, and facilities that produce these therapies. Combining the incremental process improvements previously mentioned results in an optimized facility, with the adjusted block flow shown in Figure 5.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

This article summarizes an alternate and more functional way to format the QOS presented in Module 2.3. Currently, it takes time and/or communications (e.g., For purpose of illustration used throughout this article, labels have been assigned to each CQA. Direct feedback from the US FDA on this pilot is shared in the discussion.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

This article summarizes an alternate and more functional way to format the QOS presented in Module 2.3. Currently, it takes time and/or communications (e.g., For purpose of illustration used throughout this article, labels have been assigned to each CQA. Direct feedback from the US FDA on this pilot is shared in the discussion.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

This article presents relevant insights on the current regulatory and technical landscape for decentralized manufacturing, with select examples of current applications, and discusses perspectives on evolving and adapting the current regulations to meet future capabilities. Nature Communications 12, no. Biotechnology Progress 36, no.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. US Food and Drug Administration.